SMS Pharmaceuticals has received a closure order from Andhra Pradesh Pollution Control Board (APPCB) for its Unit -1 located at Kazipalli industrial area Medak District, Andhra Pradesh for non compliance of certain conditions.
Most of the conditions were already complied and the same is being communicated to APPCB immediately. However, the company is having six more manufacturing facilities in addition to the above said unit and all are operating without any impediments. The company is taking all possible steps to revoke the orders shortly.
SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. It is focused on API manufacturing and is the single largest producer of anti ulcer products and is renowned among the clientele for the excellent quality of product and customer service.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1779.35 |
| Dr. Reddys Lab | 1267.05 |
| Cipla | 1397.75 |
| Zydus Lifesciences | 1085.45 |
| Lupin | 2248.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: